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Objective: To explore the correlation between in vivo placental volumetric parameters in
the first trimester of pregnancy and ex vivo parameters of fetoplacental vascular function
after delivery.
Methods: In ten singleton physiological pregnancies, placental volume (PV) and
uteroplacental vascular volume (uPVV) were measured offline in three-dimensional
ultrasound volumes at 7, 9, and 11 weeks gestational age (GA) using Virtual Organ
Analysis and Virtual Reality. Directly postpartum, term placentas were ex vivo dually
perfused and pressure in the fetoplacental vasculature was measured to calculate
baseline pressure (pressure after a washout period), pressure increase (pressure after
a stepwise fetal flow rate increase of 1 mL/min up to 6 mL/min) and flow-mediated
vasodilation (FMVD; reduction in inflow hydrostatic pressure on the fetal side at 6 mL/min
flow rate). Correlations between in vivo and ex vivo parameters were assessed by
Spearman’s correlation coefficients (R).
Results: Throughout the first trimester, PV was negatively correlated with pressure
increase (Rgrowth = −0.84) and, at 11 weeks GA, also positively correlated with FMVD
(R = 0.89). At 7 weeks GA, uPVV and uPVV/PV ratio were negatively correlated with
pressure increase (R = −0.58 and R = −0.81, respectively) and positively correlated
with FMVD (R = 0.62 and R = 0.90, respectively).
Discussion: Mainly in the early first trimester, larger placental volumetric parameters
are associated with lower pressure and more FMVD in the fetoplacental vasculature
after delivery. This may suggest that larger and/or more vascularized placentas
in early pregnancy have better adaptive mechanisms and possibly lead to better
pregnancy outcomes.
Keywords: placental development, ultrasound, virtual reality, vascular volume, placental perfusion, vascular
resistance
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INTRODUCTION
Placenta-related pregnancy complications, such as preeclampsia
(PE) and fetal growth restriction (FGR), are highly prevalent
and not only affect fetal development and pregnancy outcome,
but also future maternal and offspring health (Barker et al.,
2007; Bellamy et al., 2007; Steegers et al., 2010). Most of these
pregnancy complications originate already in the first trimester
of pregnancy (Steegers-Theunissen et al., 2013). Within this
time window, development of the placental bed takes place,
which is characterized by remodeling of the uterine spiral
arteries, thereby creating a low-resistance circulation. Adequate
remodeling is crucial to placental development, subsequently
affecting embryonic and fetal health (Jauniaux et al., 2006; Burton
et al., 2009). After the placental vascular network has been
formed in early pregnancy, capillary growth continues until
delivery, mediated by various growth factors. From mid-gestation
onward, there is an exponential growth in vascular volume of
fetoplacental vessels to accommodate the needs of the growing
fetus (Gude et al., 2004).
Non-invasive assessment of in vivo placental development
remains challenging, since the value of available markers of
placental function and development is limited. Most commonly,
placental function is assessed by the use of derivatives
of the placental circulation. For example, abnormal uterine
artery Doppler waveforms have been related to pregnancy
complications, such as pregnancy-induced hypertension and
PE (Schuchter et al., 2001; Rizzo et al., 2008). An innovative
method to determine placental development resulted from
the introduction of Virtual Organ Computer-aided Analysis
(VOCAL), which enables the assessment of three-dimensional
(3D) placental volume (PV) measurements and uteroplacental
vascularisation indices (i.e., vascularisation indices, flow indices
and vascularisation-flow indices). These parameters have all been
associated with adverse outcomes, such as miscarriage, PE and
FGR (Hata et al., 2011; Reus et al., 2013; Eastwood et al., 2017).
A newly developed technique is Virtual Reality (VR) which
can be combined with measurements of 3D power Doppler
(PD) ultrasound volumes and visualizes the placental circulation
from early pregnancy onward, in three dimensions with depth
perception. As previously demonstrated by Reijnders et al. (2018)
this technique is feasible and reliable for use in the first trimester
of pregnancy to measure placental parameters, that reflect PV and
uteroplacental vascularization of the uterine/maternal side (i.e.,
the placental bed).
Ex vivo assessment of the fetoplacental vasculature can be
performed using dual-sided placental perfusion, an experimental
model to study fetal vascular reactivity of a single cotyledon
directly after birth. Unlike most other vascular systems, the
fetoplacental vasculature is not innervated. Local vascular tone
and fetal cardiac output are the main determinants of blood
flow through these vessels, regulated by circulating and locally
produced hormones and vasoactive compounds (Walker and
McLean, 1971). Therefore, flow-mediated pressure changes in the
ex vivo dual-sided perfused cotyledon are a measure of vascular
resistance in the placenta. Jones et al. (2015) have already shown
that there is a significant correlation between vascular resistance
measured in vivo (i.e., umbilical artery Doppler velocimetry
at term) and ex vivo placental perfusion. However, no study
has yet assessed the relation between in vivo parameters of
early placental vascular development and ex vivo placental
vascular perfusion.
Since early non-invasive assessment of placental development
is challenging and it is unknown whether available markers
actually represent placental function later in pregnancy, the
aim of this study was to explore whether correlations exist
between in vivo ultrasound parameters of first-trimester placental
(vascular) development and ex vivo parameters of fetoplacental
vascular reactivity at delivery. Not only will this provide
better insight in the pathophysiology of placental disorders, it
could also demonstrate the need for earlier evaluation of the
placental circulation.
MATERIALS AND METHODS
This explorative study was conducted within the Virtual placenta
study, embedded in the Rotterdam Periconception Cohort
(Predict Study), which is an ongoing prospective cohort study
performed at the Department of Obstetrics and Gynecology
of the Erasmus MC, University Medical Center in Rotterdam,
Netherlands (Steegers-Theunissen et al., 2016). Women who
participated in the Predict study before 10 weeks gestational age
(GA), were also invited to participate in the Virtual Placenta
study that was carried out between January 2017 and March
2018. Pregnancies conceived either spontaneously or through
assisted reproduction techniques (ART) were eligible. The study
protocol has been approved by the Erasmus MC Institutional
Review Board (MEC 2015-494). All participating women and
their partners signed written informed consent at enrolment,
also on behalf of their unborn child. Women were asked for
consent to use their placenta for research purposes after delivery.
Women with multiple pregnancies, (gestational) diabetes, viral
infections (e.g., HIV) or placental anomalies were not eligible for
inclusion in this subset.
Study Parameters
Maternal characteristics were obtained from self-reported
questionnaires filled out upon enrolment. First-trimester body-
mass index (BMI) and blood pressure were also measured at
intake. After delivery, participating women again filled out a
questionnaire on pregnancy and birth outcomes. The retrieved
information was checked with data from medical records and
delivery reports where available.
Ultrasound
Participants underwent serial 3D ultrasound examinations at 7,
9, and 11 weeks GA to obtain volumes encompassing the whole
embryo and placenta. Ultrasound examinations were performed
by experienced sonographers only, using a Voluson E8 or E10
system (GE Medical Systems, Zipf, Austria). In the first trimester,
3D ultrasound examinations were performed using a transvaginal
6–12 MHz transducer. Vasculature of the complete placenta and
embryo was imaged using PD US with standardized setting
Frontiers in Physiology | www.frontiersin.org 2 January 2020 | Volume 11 | Article 6
fphys-11-00006 January 22, 2020 Time: 17:45 # 3
Hitzerd et al. In vivo and ex vivo Placental Parameters
(PD gain “−8.0,” pulse repetition frequency (PRF) “0.6 kHz,”
wall motion filter (WMF) “low1,” quality “high”). To minimize
artifacts and measurement errors by movement, participants
were asked to hold their breath for approximately 30 s during
image acquisition. All ultrasound examinations were performed
according to international guidelines on safe use of Doppler
ultrasound in the first trimester of pregnancy (ALARA-principle)
and, as such, total scanning time was kept as low as possible with
a maximal duration of 30 min and a maximal thermal index of 1.3
(The British Medical Ultrasound Society, 2009; Bhide et al., 2013;
World Federation For Ultrasound in Medicine and Biology, 2013;
Reijnders et al., 2018).
Offline 3D Measurements
Placental volume (PV) measurements were performed with
oﬄine specialized VOCAL software (4D View, GE Medical
System) according to standardized methods, to reconstruct the
trophoblast (Reus et al., 2013).
Uteroplacental vascular volume (uPVV) was measured using
a VR desktop system (Figure 1). VR enables visualization
of a 3D volume as a true hologram, which allows for
depth perception and thus more optimal assessment of the
FIGURE 1 | Visualization of a three-dimensional power Doppler
utero-placental vascular volume in Virtual Reality. On the left; complete
three-dimensional power Doppler (3D PD) vascular volume at 9 weeks of
gestation. On the right; Using gray values of the utero-placental tissue, a
virtual brush allows to erase vascular voxels up to the myometrial-placental
tissue interface margin, leaving uteroplacental vascular volume (uPVV) to be
measured by threshold-based segmentation. Lower inserts; two-dimensional
power Doppler (2D PD) image with complete vasculature in color delineated
by dashed white line (left), placental vascularization delineated by dashed
yellow line (right). The * indicates ‘embryonic structures’.
uteroplacental vascularization. The VR desktop is a validated
system composed of a personal computer using the V-Scope
volume rendering application, a two-dimensional (2D) monitor
which displays the user interface, a 3D monitor to display the
volume, a tracking system allowing for interaction of the observer
with the 3D volume, a pair of stereoscopic glasses to enable depth
perception and a six-degrees of freedom mouse for 3D volume
manipulation (Baken et al., 2015). By thresholding the 8-bit
(range 0–255) Doppler magnitude data, semi-automatic volume
measurements of the uPVV were obtained. To enable the most
optimal visualization of the uteroplacental vasculature, the lower-
Doppler threshold level was set at a value of 100, which means
that semi-automatic calculations only color and count by voxels
with a Doppler value of 100 or higher. First, embryonic structures
were removed from the segmentation. Then, the difference in
echogenicity between the myometrium and placenta was used to
erase the vessels up to the myometrial-placental border, thereby
leaving the maternal vascularization of the uteroplacental bed
for volume assessment. Currently it is not possible to distinct
between the maternal blood space and embryonic vasculature
within the uPVV. A more detailed description and validation
of the methods for uPVV measurements has previously been
published (Reijnders et al., 2018). After VOCAL and VR
measurements, uPVV was divided by PV to calculate a placental
vascular volume ratio (uPVV/PV ratio). Due to limited image
quality or study inclusion after 7 weeks GA, measurements of PV
and uPVV could not be performed for all included pregnancies
and/or study visits.
Placental Perfusion
The perfusion model used in our study has been previously
described in detail by Hitzerd et al. (2019). In short, term
placentas were collected immediately after delivery and fetal
circulation was established by cannulating a corresponding
chorionic artery and vein of an intact cotyledon. Fetal flow rate
was started at 1 mL/min. When cannulation was successful,
the cotyledon was cut from the placenta and placed inside
the perfusion chamber. Maternal circulation (constant flow rate
of 12 mL/min) was created by placing four blunt cannulas
in the intervillous space. Venous outflow was collected in a
reservoir underneath the cotyledon and run back to the maternal
reservoir. Perfusion media consisted of Krebs-Henseleit buffer,
FIGURE 2 | Stepwise increase in fetal flow rate leading to increase in pressure (representative).
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supplemented with heparin (5000 IU, 0.5 mg/L) and aerated with
95% O2 – 5% CO2. A placental washout period of approximately
30 min was performed before starting an experiment. Changes
in pressure on the fetal side of the placenta were measured by
pressure transducers and recorded throughout the experiment
using acquisition software (Biopac, Goleta, CA, United States).
When a stable baseline pressure was reached after the washout
period, the fetal flow rate was increased stepwise with 1 mL/min,
until a flow rate of 6 mL/min was reached. After each step
a new steady state in pressure was awaited before continuing
with the next step (Figure 2). The parameters baseline pressure,
total pressure increase and flow-mediated vasodilation (FMVD)
were used for analysis. Total pressure increase was defined
as the difference between baseline at pressure at start of the
experiment and the new steady state at a flow rate of 6 mL/min.
As previously described by Jones et al. (2015) FMVD is the
percentage of reduction in hydrostatic pressure on the fetal
side as a result of increased flow rate, measured at a flow
rate of 6 mL/min.
Statistical Analysis
Because of skewed distributions of most parameters, data
are presented as medians (interquartile range). To identify
correlations between in vivo and ex vivo measurements,
Spearman’s rank correlation coefficients (R-values) were used
and correlations were plotted in scatterplots. To further
evaluate these correlations, linear mixed models were used
to calculate individual slopes for each participant to establish
placental growth trajectories throughout the first trimester
(at 7, 9, and 11 weeks GA). In these models, uPVV, PV
and the uPVV/PV ratio were transformed using a cubic
root. The individual slopes were then also correlated with
ex vivo parameters using Spearman’s correlation coefficients.
All analyses were performed using SPSS software (version
21.0; SPSS Inc., Chicago, IL, United States) and RStudio
Statistics (version 3.5.0, 2018). Correlations >0.5 were
considered relevant and P-values <0.05 were considered
statistically significant.
RESULTS
Baseline Characteristics
In this explorative study, twelve women were included, of whom
ten placentas were successfully perfused. Baseline characteristics
of these ten women are provided in Table 1. Women had a
median age of 31.9 years (29.7–37.1), 40% were nulliparous
and 90% conceived spontaneously. None of the women smoked
or used alcohol during pregnancy. In 60% of the women,
the mode of delivery was an elective caesarean section (two
nulliparous – and four multiparous women), all because a of
breech position and/or previous caesarean section. Two women
delivered spontaneously and another two women underwent
an emergency caesarean because of failure to progress. Median
birth weight was 3365 grams (2835–3425) and 70% of the
offspring was male. None of the pregnancies were complicated
by PE or any other pregnancy complication. All infants were
TABLE 1 | Baseline characteristics (n = 10).
Characteristics
Maternal
Age at intake (years) 31.9 (29.7–37.1)
Nulliparous 4 (40%)
Mode of conception
− Spontaneous 9 (90%)
− IVF/ICSI 1 (10%)
Geographic origin
− Dutch 7 (70%)
− Western 1 (10%)
− Non-western 2 (20%)
Educational level
− Low 0 (0%)
− Intermediate 3 (30%)
− High 7 (70%)
BMI, first-trimester (measured) 22.8 (21.7–32.5)
Periconceptional folic acid supplement use 10 (100%)
Median first trimester RR (intake)
− Systolic 108.0 (99.0–110.0)
− Diastolic 65.0 (60.0–70.0)
Periconceptional smoking 1 (10%)
Periconceptional alcohol use 0 (0%)
At delivery
Gestational age at delivery 38+5 (37+4–39+1)
Mode of delivery
− Vaginal 2 (20%)
− Elective caesarean 6 (60%)
− Emergency caesarean 2 (20%)
Placental weight 395 (322–451)
Placental weight <p10 at birth 2 (20%)
Histology: distal villous hypoplasia 1 (10%)
Neonatal
Birth weight 3365 (2835–3425)
Small-for-gestational-age 1 (10%)
Sex
− Male 7 (70%)
− Female 3 (30%)
Data are expressed as median (interquartile range) or number (percentage).
born at term (i.e., >37 weeks GA), and one infant was small-
for-gestational-age (birth weight below the 10th percentile)
(Hoftiezer et al., 2019). Median placental weight was 395
grams (322–451), and of two placentas, weight was below the
10th percentile.
Placental Vascular Measurements
For the ten included pregnancies, six women had multiple
measurements available for PV and eight women had
multiple measurements available for uPVV. Three women
had measurements available at all weeks for PV, four women
had available measurements at all weeks for uPVV. A total
of five measurements of PV and uPVV were available at
7 weeks GA, eight measurements were available of PV and
nine of uPVV at 9 weeks GA, and five measurements were
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available of PV and seven of uPVV at 11 weeks GA. Median
values for in vivo placental measurements per week GA
are displayed in Table 2 and increased from a median of
3.26 cm3 (0.96–6.40) at 7 weeks GA to 13.36 cm3 (6.27–
30.08) at 11 weeks GA for uPVV, a median of 20.15 cm3
(12.95–23.90) at 7 weeks GA to 92.76 cm3 (69.18–125.36)
at 11 weeks GA for PV, and a median of 0.16 (0.08–0.23)
at 7 weeks GA to 0.17 (0.10–0.35) at 11 weeks GA for
the uPVV/PV ratio.
Placental Perfusion
Median GA at delivery was 38+5 (37+4–39+1) weeks. Median
values for ex vivo placental measurements are displayed
in Table 3. Median baseline pressure at the starting flow
rate of 1 mL/min was 21 mmHg (19–25) mmHg, which
increased to 32.5 mmHg (23.8–36.0) at 6 mL/min, leading
to a total pressure increase of 10.5 mmHg (3.0–13.0)
(Figures 3A,B). Median FMVD at 6 mL/min was 50%
(50–100) (Figure 3C).
Correlations
Correlations between in vivo and ex vivo measurements are
depicted in Table 4 and Figure 4. PV was negatively correlated
with pressure increase at 7 weeks GA (R = −0.53), 9 weeks GA
(R = 0.74) and 11 weeks GA (R =−0.98).
At 11 weeks GA, PV was positively correlated with baseline
pressure (R = 0.62) and FMVD (R = 0.89). uPVV was negatively
correlated with pressure increase (R = −0.58) and positively
correlated with FMVD (R = 0.62) at 7 weeks GA. No correlations
between uPVV and ex vivo parameters were observed at 9 and
11 weeks GA. The uPVV/PV ratio was negatively correlated
with pressure increase (R = −0.81) and positively correlated
with FMVD (R = 0.90) at 7 weeks GA. At 11 weeks GA, a
negative correlation was observed between the uPVV/PV ratio
and FMVD (R = −0.67), although this correlation was not
statistically significant.
When studying the correlations between in vivo placental
growth throughout the first trimester (i.e., slopes of placental
parameters) and cross-sectional ex vivo placental parameters,
a significantly negative correlation was observed between first-
trimester PV growth and FMVD (Rgrowth = −0.84) and between
uPVV/PV ratio and FMVD (Rgrowth = −0.90). Also, relevant
positive correlations, although not statistically significant, were
observed between PV growth and FMVD (Rgrowth = 0.50)
and between uPVV/PV ratio growth and pressure increase
(Rgrowth = 0.51).
TABLE 3 | Median and ranges of ex vivo placental measurements at term.
n = 10 Median IQR
Pressure at baseline 21.0 19.0–25.0
Total pressure increase (mmHg) 10.5 3.0–13.0
End pressure (mmHg) 32.5 23.8–36.0
FMVD at 6 ml/min 50.0 50.0–100.0
FMVD, flow-mediated vasodilation (% pressure reduction from peak to new steady
state); IQR, interquartile range.
DISCUSSION
The results of this study suggest that, mainly in the early first
trimester, larger placental volumetric parameters, measured by
3D ultrasound and VR technique, are associated with lower
pressure and more FMVD in the fetoplacental vasculature
after delivery. Correlations between in vivo placental growth
throughout the first trimester and ex vivo placental parameters
were negative for the growth of PV and pressure increase
(R = −0.84), but positive for FMVD (R = 0.50) although
not statistically significant. In contrast, a negative correlation
existed between the growth of first-trimester uPVV/PV ratio and
FMVD (R =−0.90).
To our knowledge, the current study is the first to
investigate associations between in vivo first-trimester ultrasound
parameters of the maternal uteroplacental circulation and third-
trimester ex vivo perfusion parameters of the fetoplacental
circulation. Previously, it has been shown by Jones et al. (2015)
that at term there is a positive correlation between in vivo
umbilical artery Doppler velocimetry and ex vivo fetoplacental
vascular resistance in placentas from uncomplicated pregnancies.
However, one should keep in mind that umbilical artery Doppler
velocimetry and ex vivo vascular resistance both represent the
fetal side of the placenta, while our placental parameters reflect
the volume and vascularization of the uterine/maternal side (i.e.,
the uteroplacental bed). In line with the results of Jones et al.
(2015) we found a negative correlation between pressure increase
at ex vivo perfusion and PV (throughout the first trimester) and
uPVV (at 7 weeks GA only). Furthermore, this corresponds with
the positive correlation that was observed between PV, uPVV
and FMVD. These findings suggest a greater ability of larger
placentas to adjust to higher pressure by vasodilation, due to
a greater compensatory capacity in the form of vasodilation.
This is contrasted by the finding that the growth trajectory of
uPVV/PV ratio was positively correlated with pressure increase
TABLE 2 | Median and ranges of measurable in vivo placental volumetric parameters per week GA.
7 weeks GA (n = 5) 9 weeks GA (n = 9) 11 weeks GA (n = 7)
Median IQR Median IQR Median IQR
PV (cm3) 20.15 12.95–23.90 44.69 25.57–57.25 92.76 69.18–125.36
uPVV (cm3) 3.26 0.96–6.40 8.80 3.97–10.61 13.36 6.27–30.08
uPVV/PV ratio 0.16 0.08–0.23 0.16 0.14–0.33 0.17 0.10–0.35
uPVV, uteroplacental vascular volume (in cm3); PV, placental volume (in cm3); uPVV/PV ratio, ratio between uPVV and PV; IQR, interquartile range.
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FIGURE 3 | Ex vivo placental perfusion parameters. (A) Shows the steady state fetoplacental pressure that was measured after each increase of flow rate. Pressure
increase was highest after the first increase of flow rate from 1 to 2 mL/min (B). (C) Shows the flow-mediated vasodilation (FMVD) per flow rate. Data (n = 10) are
shown as median (interquartile range).
TABLE 4 | Correlations between in vivo and ex vivo placental parameters per week GA.
Placental parameter R7weeks R9weeks R11weeks Rgrowth
PV
– pressure at baseline −0.05 −0.05 0.62 0.25
– total pressure increase −0.53 −0.74* −0.98* −0.84*
– FMVD at 6ml/min 0.05 −0.04 0.89* 0.50
uPVV
– pressure at baseline 0.15 −0.40 0.42 0.03
– total pressure increase −0.58 0.14 0.22 −0.25
– FMVD at 6ml/min 0.62 −0.25 −0.21 0.15
uPVV/PV ratio
– pressure at baseline −0.24 −0.01 0.05 −0.15
– total pressure increase −0.81 0.12 0.36 0.51
– FMVD at 6ml/min 0.90* 0.21 −0.67 −0.90*
R = Spearman’s correlation coefficient. Relevant correlations in bold. *Significant at level <0.05. FMVD, flow-mediated vasodilation (% pressure reduction from peak to
new steady state); uPVV, uteroplacental vascular volume (in cm3); PV, placental volume (in cm3); uPVV/PV ratio, ratio between uPVV and PV; R, correlation coefficient.
and negatively with FMVD, which suggests that placentas
with more vascular development (i.e., more increase of uPVV
compared to PV throughout the first trimester) demonstrate
higher pressure and less vasodilation in response to flow. Since
PV and uPVV only reflect the maternal part of the placental
circulation, a possible explanation for this correlation could be
that less vascularized placentas in the first trimester have been
exposed to higher pressure in utero and therefore show more
pressure increase and less vasodilation ex vivo.
A larger PV at 11 weeks GA was associated with higher
baseline pressure in this group of uncomplicated pregnancies.
In line with this, previous research by our group showed
that baseline pressure during ex vivo perfusion in placentas
of pregnancies complicated by early onset PE was significantly
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FIGURE 4 | Scatterplots depicting correlations between in vivo and ex vivo placental parameters. This figure shows the correlations of the ex vivo parameters
measured postpartum and PV (A), uPVV (B) and the uPVV/PV ratio (C) at 7 weeks GA (black circles), 9 weeks GA (orange circles) and 11 weeks GA (blue circles).
FMVD, flow-mediated vasodilation (% reduction in pressure from peak to new steady state); PI, pressure increase; PV, placental volume (in cm3); uPVV,
uteroplacental vascular volume (in cm3); uPVV/PV ratio, ratio between uPVV and PV.
lower compared to healthy placentas (Hitzerd et al., 2019). These
placentas were significantly smaller, exposed to higher blood
pressure in vivo, and displayed altered vascular responsiveness.
However, the direct response to flow rate increase was not
studied. Interestingly, Jones et al. (2015) did not find the same
positive correlation between in vivo umbilical artery Doppler
velocimetry and ex vivo fetoplacental vascular resistance in
placentas of pregnancies complicated by FGR as in healthy
placentas. Since smaller first-trimester PV is associated with
the occurrence of FGR and PE (Hafner et al., 2003), it
would be interesting to study whether the correlations seen
in the current study also exist in placentas of pregnancies
complicated by placental insufficiency (e.g., FGR or PE).
Only one patient in the current study delivered a small-for-
gestational-age infant, therefore it was not possible to show
a clear correlation with fetal growth, however, values of this
case were not outliers. Comparing histology of the included
placentas did not provide additional explanations for our
results (data not shown). Histological analysis was performed
according to the Amsterdam criteria (Khong et al., 2016) and
included maternal stromal-vascular lesions, fetal stromal vascular
lesions, infectious inflammatory lesions, immune/idiopathic
inflammatory lesions, massive perivillous fibrin(oid) deposition,
abnormal placental shape or umbilical insertion site, morbidly
adherent placentas (accreta), meconium-associated changes and
increased circulating nucleated red blood cells.
The differences in findings across the increasing gestational
ages could be attributed to the unplugging of the spiral arteries
around 9 weeks gestation. In early gestation, cytotrophoblast
plugs occlude the spiral arteries, preventing perfusion of the
intervillous space to safeguard a low-oxygen environment
(Burton et al., 2003), which is needed for vasculogenesis and
cytotrophoblast proliferation (Genbacev et al., 1997). Later in the
first trimester, extravillous cytotrophoblast cells invade around
the spiral arteries, initiating their remodeling and unplugging
(Pijnenborg et al., 1980). This leads to a low-resistance circulation
with an increased perfusion capacity and reduced blood flow
velocity into the intervillous space (Ji et al., 2013; Roberts, 2014).
We hypothesize that these vascular modifications impact PV and
uPVV measurements and, especially after 9 weeks GA, could
result in less pressure increase and more FMVD after delivery
for larger PV and uPVV in the late first trimester. We did not
demonstrate such an impact for uPVV in this study, but we did
observe a negative correlation between PV and pressure increase
and a positive correlation between PV and FMVD, in particular
after 9 weeks GA.
This study is strengthened by the longitudinal data collection,
creating a unique data set combining patient characteristics with
Frontiers in Physiology | www.frontiersin.org 7 January 2020 | Volume 11 | Article 6
fphys-11-00006 January 22, 2020 Time: 17:45 # 8
Hitzerd et al. In vivo and ex vivo Placental Parameters
in vivo and ex vivo measurements of the placenta. On the other
hand, there is a large time gap between our measurements by
first-trimester ultrasound and perfusion postpartum. Alterations
in placental development during second- and third trimesters
could have impacted our results, since capillary growth continues
until delivery to accommodate the growing fetus, resulting in
an exponential increase in volume of placental vessels in the
third trimester (Gude et al., 2004). Still, it is known that failure
of the maternal spiral arteries to properly remodel in early
pregnancy is already associated with higher fetoplacental vascular
resistance later in pregnancy (Acharya et al., 2005; Jones et al.,
2015). Despite ongoing alterations, the foundation for placental
vascular development is established in the first trimester, and
this knowledge supports the correlations found in this study.
Further, it remains uncertain whether mode of delivery could
have affected vascular resistance. Most placentas in our study
were obtained after elective caesarean section (70%) and have
not been subjected to labor. Only two placentas were delivered
vaginally and one after emergency caesarean section. There
is much debate in literature whether mode of delivery affects
placental perfusion experiments. On the one hand it has been
demonstrated that placentas after vaginal delivery show increased
oxidative stress and inflammatory cytokines on both gene- and
protein levels (Cindrova-Davies et al., 2007). On the other
hand, multiple studies showed no difference in placental barrier
function during ex vivo perfusion for delivery mode (Mathiesen
et al., 2010; Conings et al., 2017). Lastly, identified correlations
should be cautiously interpreted due to the small sample size of
the study, which also hampered correction for multiple testing.
Furthermore, such small sample size could lead to bias. However,
values of patients with characteristics that stood out from the rest
(e.g., IVF pregnancy, periconceptional smoking, spontaneous
delivery), were not outliers. Also, male/female differences could
introduce bias. Unfortunately only 3 female neonates were
included in this study which made verification of bias impossible,
although they were not outliers. A larger sample size would have
probably strengthened the identified correlations, but since this
was an explorative study and ex vivo placental perfusion is a
difficult, expanding the group size within a reasonable time frame
was not feasible.
In conclusion, we showed that in vivo larger first-trimester
PV and uPVV are associated with less pressure increase and
higher FMVD of the ex vivo fetoplacental vasculature at term,
suggesting that enhanced adaptive mechanisms after delivery
relate to a more optimal development of the placenta early in
pregnancy. First-trimester evaluation of PV and vascularization
could therefore be of value to predict placental function in
later pregnancy, thereby providing future opportunities for early
prevention as well as treatment of placenta-related pregnancy
complications. As a next step toward this, future research
should focus on validation of these measurements in the general
population and in placentas from complicated pregnancies
(FGR and/or PE).
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